News | Kneu Health

Skip to main content

How it works Providers and Payers Parkinson’s disease Dementia

Company

About
How it works
Our science
News

Services

Parkinsons
Dementia
Providers and Payers

Legal

Cookie Policy
Privacy Policy
Terms of Use

Contact & Support

Request a demo
General inquiries
Patients Support
Frequently Asked Questions

Follow us on Social media

Kneu Health is a MHRA registered and FDA cleared medical device.

Kneu Health Ltd is registered in England and Wales with company number 14492037 and its registered office is at First Floor, 100 Victoria Embankment, London, EC4Y 0DH, United Kingdom. It is registered under the Data Protection Act No. ZB541090. U.S. Patent No. 12,569,185. © 2026 Kneu Health Ltd. All rights reserved.

FilterCompany news Partnerships Impact Platform updates Perspectives

Company news | Partnerships

Kneu Health Joins Cedars-Sinai Accelerator to Revolutionize Parkinson's Disease and Dementia in the US

August 2, 2024

Impact | Platform updates

Pioneer Intervention Program: Our Patient-Led Design Initiative

June 17, 2024

Company news | Impact

NHS Partnership Announcement: Kneu Health & Leeds Teaching Hospital Trust

May 21, 2024

Company news

Introducing Hans Boerma and Phil Bromley: Pioneering Healthcare Innovation at Kneu Health

May 15, 2024

Company news | Partnerships

Groundbreaking Partnership: NHS Awards First Service Contract to Kneu Health

March 11, 2024

Perspectives

Reimagining Neurology Care with Data and Digital Technologies

March 9, 2024

Company news | Impact

Kneu Health: Pioneering Health Tech Innovation, Recognized in Prestigious Programs

December 13, 2023

Platform updates

Ensuring Regulatory Excellence

November 15, 2023

Company news

Kneu Health Announces Key Appointments to its Board of Directors

October 24, 2023

Showing 19–27 of 28 results